Qingfa Pharmaceutical

Chongqing Qingfa Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Established in 1993 and based in Chongqing, the company is globally recognized as a leading producer of anti-malarial drugs, including chloroquine phosphate and primaquine phosphate. It is a key subsidiary of the Taiji Group, which has been integrated into the China Resources (CR) Pharmaceutical network. The company operates modern, GMP-certified production facilities and serves both domestic markets and international organizations such as the WHO. Its portfolio focuses on high-quality chemical synthesis for infectious diseases, rheumatology, and various other therapeutic areas.